zPREDICTA - Ownership and Business Overview

Life ScienceCompany

zPREDICTA Ownership

Who owns zPREDICTA?

zPREDICTA is owned by Predictive Oncology. It was acquired on December 1, 2021.

zPREDICTA Business Overview

Where is zPREDICTA headquartered?

zPREDICTA is headquartered in San Jose, California.

What sector is zPREDICTA in?

zPREDICTA is a life science company.

When was zPREDICTA founded?

zPREDICTA was founded in 2014.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 389 acquisitions of life science companies in 2021, including 45 acquisitions by private equity firms, and 344 by strategics.

zPREDICTA

zPREDICTA, Inc.

5941 Optical Court,
San Jose, California 95138
United States,
www.zpredicta.com

zPREDICTA develops tumor-specific in vitro models for oncology drug discovery and research. Its mission is to accelerate the drug development process for pharmaceutical clients and partners. Based on their proprietary models, zPREDICTA offers preclinical testing services to clients in the biopharmaceutical industry and through its partnership with a large pharma company. zPREDICTA was founded in 2014 and is based in San Jose, California.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.